Shribman, S;
Heller, C;
Burrows, M;
Heslegrave, A;
Swift, I;
Foiani, MS;
Gillett, GT;
... Warner, TT; + view all
(2020)
Plasma Neurofilament Light as a Biomarker of Neurological Involvement in Wilson's Disease.
Movement Disorders
10.1002/mds.28333.
(In press).
Preview |
Text
mds.28333.pdf - Published Version Download (235kB) | Preview |
Abstract
Objective: To identify a biomarker for neurological involvement in WD. / Methods: Neuronal and glial‐specific proteins were measured in plasma samples from 40 patients and 38 age‐matched controls. Patients were divided into neurological or hepatic presentations and those with recent neurological presentations or deterioration associated with non‐adherence were subcategorized as having active neurological disease. Unified WD Rating Scale scores and copper indices were recorded. / Results: Unlike copper indices, neurofilament light (NfL) concentrations were higher in neurological than hepatic presentations. They were also higher in those with active neurological disease when controlling for severity and correlated with neurological examination subscores in stable patients. / Conclusion: NfL is a biomarker of neurological involvement with potential use in guiding chelation therapy and clinical trials for novel treatments.
Archive Staff Only
 |
View Item |
